Advertisement
AtriCure, Inc.

AtriCure, Inc. (ATRC) Stock Overview

Explore AtriCure, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ATRCNASDAQ
HealthcareMedical - Instruments & Supplies
$27.30
$0.39(1.43%)
U.S. Market opens in 9h 48m
Advertisement

AtriCure, Inc. (ATRC)

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-286.66
EPS (TTM)$-0.10
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$23.13
3 Months$29.73
1 Year Target$37.37

ATRC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AtriCure, Inc. (ATRC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.98, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $37.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -286.66 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.43%
5-Day Change
2.29%
1-Month Change
3.88%
3-Month Change
-7.11%
6-Month Change
-31.27%
Year-to-Date (YTD) Change
-30.99%
1-Year Change
-20.13%
3-Year Change
-42.10%
5-Year Change
-63.09%
All-Time (Max) Change
93.89%

Contact Information

513 755 4100
7555 Innovation Way, Mason, OH, 45040

Company Facts

1,300 Employees
IPO DateAug 5, 2005
CountryUS
Actively Trading

Frequently Asked Questions